3Yki Jarviner H. Pathogenesis of non-insulin dependent diabets mellitus. Lancet, 1994, 343, 91--5.
4World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Part I: Report of a WHO Consultation: Daignosis and Clasaificaiton of Diabetes Mellitus. Geneva, World Healt Org, 1999.
5Leahy JL. Natural history of β - cell dysfunction in NIDDM. Diabetes Care, 1990, 13: 992--1010.
6American Diabetes Associtation. The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care, 1996, 20(supple):54.
7Robertson RP. Differentiating glucose toxicity from glucose Desensitixation:A new message from the insulin gene. Diabetes 1994, 43(9) : 1085--7.
8Ilk ova H, Glaser B, Tunckale A, et al. Induction of long - term glycemic control in newly diagnosed type 2 patients by transient intensive insulin treat meat. Diabetes Care, 1997, 20: 1353--6.
2Yki Jarvinen H.Pathogenesis of non-insulin dependent diabetes mellitus[J],1994.
3World Health Organization.Definition Diagnosis and Classification of Diabetes Mellitus and Its Complications :Part 1:Report of a WHO Consultation: Diagnosis and Classification of Diabetes Mellitus,1999.
4Larsson H;Ahren B.Glucose-dependent arginine stimulation test for characterization of islet function:studies on reproducibility and priming effect of arginine[J],1998.
5Alberti KG;Daly ME;Robinson A.The short insulin tolerance test is safe and reproducible[J],1999.
6Leahy JL;Weir GC.Beta cell dysfunction in hyperglycemia rat models:Recovery of glucose induced insulin secretion with lowering of the ambient glucose level[J],1991.
7Leahy JL.Natural history of β-cell dysfunction in NIDDM[J],1990.
8Larsson H;Ahren B.Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance[J],2000(5).
9Porte D Jr.β cell in typeⅡdiabetes mellitus[J],1991.
10Shanker RR;Zhu JS;Baron AD.Glucosamine infusion in rats mimics the β-cell dysfunction of non-insulin-dependent diabetes mellitus[J],1998(5).
4Lenhard ML, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump thrapy. Arch Intern Med 2001 ; 161 (9) :2293 - 2300.
5Wessberg B J, Antisdel IJ, Seshadri R. Insulin pump therapy: a mela - analysis. J Diabetes Care,2003 ;26 (4) : 1079 - 1087.
6Bode Bw.Reduction of severe hypoglycemia with long-term continuous subcutanceous insulin infusion in type 1 diabetes[J].Diabetes Spectrum,1994,7(2):80～84.
8Laurizen T,Pramming S,Deckert T,et al.Pharmacokinetics of continuous subcutaneous insulin infusion[J].Diabetologia,1983,24:326～329.
9Hkova H,Glaser B,Tunckale A,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatmeat[J].Diabetes Care,1997,20:1 353～1 356.
10Pratley RE,Weyer C.The role of impaired early insulin secretion in the pathogenesis of type 2 diabetes mellitus[J].Dialetologia,2001,44:929～945.
